From mboxrd@z Thu Jan 1 00:00:00 1970 X-Msuck: nntp://news.gmane.io/gmane.text.pandoc/28474 Path: news.gmane.io!.POSTED.blaine.gmane.org!not-for-mail From: John MacFarlane Newsgroups: gmane.text.pandoc Subject: Re: Pandoc stopped rendering tables and contents from the YAML block Date: Thu, 27 May 2021 14:16:11 -0700 Message-ID: References: <1abeeca5-7362-441d-907a-08df53958b28n@googlegroups.com> <932560f4-7866-4fd4-90e7-4797e23fab20n@googlegroups.com> Reply-To: pandoc-discuss-/JYPxA39Uh5TLH3MbocFFw@public.gmane.org Mime-Version: 1.0 Content-Type: text/plain; charset="UTF-8" Content-Transfer-Encoding: quoted-printable Injection-Info: ciao.gmane.io; posting-host="blaine.gmane.org:116.202.254.214"; logging-data="20132"; mail-complaints-to="usenet@ciao.gmane.io" To: Julio Vera , pandoc-discuss Original-X-From: pandoc-discuss+bncBCJZJHG45QDBBKEYYCCQMGQENQ7LREI-/JYPxA39Uh5TLH3MbocFFw@public.gmane.org Thu May 27 23:16:27 2021 Return-path: Envelope-to: gtp-pandoc-discuss@m.gmane-mx.org Original-Received: from mail-pj1-f56.google.com ([209.85.216.56]) by ciao.gmane.io with esmtps (TLS1.3:ECDHE_RSA_AES_128_GCM_SHA256:128) (Exim 4.92) (envelope-from ) id 1lmNMh-0004yF-4W for gtp-pandoc-discuss@m.gmane-mx.org; Thu, 27 May 2021 23:16:27 +0200 Original-Received: by mail-pj1-f56.google.com with SMTP id gq1-20020a17090b1041b029015dad62a207sf3376752pjb.9 for ; Thu, 27 May 2021 14:16:27 -0700 (PDT) ARC-Seal: i=2; a=rsa-sha256; t=1622150186; cv=pass; d=google.com; s=arc-20160816; b=EYJ1VgbWwitBsnP0eTdrRC8lEZWPSYfGgWdAEVCQedaSDSd+GK2O8meuyXngm88+/i FK+BrOGHRwHtWh6Gpp9kKgRGUvZEjOr2t8sPBP0QyWDg3ujsb8NPNXRd1PTvTEpLDDDa BSjA7PvszYStDEVZcQ0rQGAu/TVjPe+mjU2qqXqStwW+4v6xPH1UegTTUci36wsIeRu8 cLbckZ5G3h3EYyGeIihMyt7nXpOQn1RviQHgjmvv7NCHL6xZaPSd/2dYnk2KxNLMCuJA PCakxKJ7PgNTxplRjLfDBFijTJiM11P88KzQEYBygrp05rH+a2sTNIz63Lb4x6AZSqTA 3HlQ== ARC-Message-Signature: i=2; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816; h=list-unsubscribe:list-subscribe:list-archive:list-help:list-post :list-id:mailing-list:precedence:reply-to:content-transfer-encoding :mime-version:message-id:date:references:in-reply-to:subject:to:from :sender:dkim-signature; bh=57P85XQNWvibMd6j9/CQXgaPjmsdkK1lEsPxMMlo4SI=; b=g8wYeYv1V9GPWfvy+CLS2+NzrZdARWY5UziuS8HcXfmQ+epvkYFSMtq+e5c/f7wp8E p7/jxAH9ucEq15sHBZQZEYGBFWvq4PmZRxdUZPk++tqFzrpWfBiRqK970aS2W9gb6BIA 3PMZhsvEBlgv0lot431rrXOFss5xajX/HVJN2RfmByTnbipObJ2LQFwaWWQvuhbVk8rM uVBKrmgXmoXiAiz6/mxLDg4ORpf+bbCqYefJqusg6TJfpqG2+PAQR/9aSRs2JSaP3eT3 ti+uqDQT3bdOkXrDiJ72ed1708xTYFkfeR4xcuN+Sp1xxPVRz3tRojkVV0hEpANMSues K9DA== ARC-Authentication-Results: i=2; gmr-mx.google.com; dkim=pass header.i=@berkeley-edu.20150623.gappssmtp.com header.s=20150623 header.b=m9TJxPqv; spf=pass (google.com: domain of jgm-TVLZxgkOlNX2fBVCVOL8/A@public.gmane.org designates 2607:f8b0:4864:20::635 as permitted sender) smtp.mailfrom=jgm-TVLZxgkOlNX2fBVCVOL8/A@public.gmane.org DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=googlegroups.com; s=20161025; h=sender:from:to:subject:in-reply-to:references:date:message-id :mime-version:content-transfer-encoding:x-original-sender :x-original-authentication-results:reply-to:precedence:mailing-list :list-id:list-post:list-help:list-archive:list-subscribe :list-unsubscribe; bh=57P85XQNWvibMd6j9/CQXgaPjmsdkK1lEsPxMMlo4SI=; b=Rw7iL2HLCUdTqlqwf8s80Mm/faZKr/SGuwLDGF3Thyqn+HtLZzJrueAeHGuoeOwmaz cnRFv+Brx4ESfsbNfvzNkFcChJ4VwRKazkZguM52e16YtqcLLgmUt4ZudqqMhvouF/k5 HSkBxdfbITstujhmK9TZJxdlviuasVNdMPJ2ahrojC5AX97wCZtuE9kcbfgPmqZkRYRB u7ozy1Ie7iS4e7ljew3sxcoNpxpj1pUP5bGQfgOd/UqGaDUGgB+Y5R9p5Kocw1LIxa4A IIIQnWOZnMQNjtWkuhw3Tj0SAr2rSArAmpMSpUUcXDH+NTfoVdbHdNA0Zndd9tfIPexR ejLw== X-Google-DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=1e100.net; s=20161025; h=sender:x-gm-message-state:from:to:subject:in-reply-to:references :date:message-id:mime-version:content-transfer-encoding :x-original-sender:x-original-authentication-results:reply-to :precedence:mailing-list:list-id:x-spam-checked-in-group:list-post :list-help:list-archive:list-subscribe:list-unsubscribe; bh=57P85XQNWvibMd6j9/CQXgaPjmsdkK1lEsPxMMlo4SI=; b=H/S0iSgklqPG+bZDMfdbkPIuna6pdoCA/JxzzRK7uY8tSluMIU8SN0EfL0BL31BqYS b/Z4NJDnksMmEgfMCD2zpVf5rP6L/dXyEZuKY+DzhRrKlpNwMFhYjGTETQ5snEdRoKFB d+70IzM7ExtO7OSGdhReKMqWeVgwmwF4FRNbeJuVNfX6Oj/LUL6ln0GsX8sQ9iCJd7zt 6+h8W7i8nrja7rpQH9+4F48DmpmKFDjOQ0kaxoUwrFr6r/8tAXnC1nvJ4L4laRfq2yVg 6MWqB03YfzFw6vCiWoWaIXMB3Zhn0A0Rb3elt5cUovzyECr6l15FpNmgzX6iHbN7urWF Original-Sender: pandoc-discuss-/JYPxA39Uh5TLH3MbocFFw@public.gmane.org X-Gm-Message-State: AOAM530YS2F22sLTFApqtHOJ/KLecY8dsaJyXYsJHcF7HxZNSkUGt5yT D7jyh5dd7rJ6vpZ4NSXljEE= X-Google-Smtp-Source: ABdhPJyrfeRjwBViLXAilx47qziZHkOisQwKPPKRuijXtInA0AdtpKvW+8KyY8XKgLMqeGicjHvrYg== X-Received: by 2002:a17:902:bd01:b029:fd:924f:b10d with SMTP id p1-20020a170902bd01b02900fd924fb10dmr4878780pls.74.1622150185818; Thu, 27 May 2021 14:16:25 -0700 (PDT) X-BeenThere: pandoc-discuss-/JYPxA39Uh5TLH3MbocFFw@public.gmane.org Original-Received: by 2002:a63:cd47:: with SMTP id a7ls2147345pgj.1.gmail; Thu, 27 May 2021 14:16:23 -0700 (PDT) X-Received: by 2002:a63:d818:: with SMTP id b24mr5612040pgh.386.1622150183511; Thu, 27 May 2021 14:16:23 -0700 (PDT) ARC-Seal: i=1; a=rsa-sha256; t=1622150183; cv=none; d=google.com; s=arc-20160816; b=w18jMG7CupRXbZ6EPhX+60NsWhL/AOLl7DE2KuWL3xKVaEDVscFu5vn2RtJUa8nEzW Ugjr2JshBPiTlA1Xl7tbr9PZ59vSN4Kc/VAOXewo9YctO6U3bIkEn1QxTa3iwVLDfoQh WhFhpVyAu0lppcWpdKL5ZEfGIsRcL0EbFkmMTfteR1agPbsCr/0aSXNwQB/uIa/YoTf9 tKuiHVy1k406vIYNw9B8+iYq4Zje2LOOMlrTdhyOFRry5LDvSjICI3eu3gZlqudVirFN VbrwymD+KJVorm2e0oqqPMQagmeL5SAU48XuDG5Rfes9CyI+UYg8erL2ASnXFSVIAo1B 55rA== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816; h=content-transfer-encoding:mime-version:message-id:date:references :in-reply-to:subject:to:from:dkim-signature; bh=h7yqQwfBl84B8srU9dRZcEG1MYbtEWmmpf3w90I9gEM=; b=sbiArGcJfNnfvGrDcwE7FyF+EjQYyH7xwn2EG+sR30Nr/9N0Q1/K6R5JKF0zLE5i5c GExTPe2Nl8PvJfbxWeOft6S/tn9A7KUm4WO7hcS/iIsRyskVriDvEdln3pnYl53JbAYh N/OxwnhWMHhBOaFne9ABOhgHiM7Fthn+bJH+/cGph+ngJWLSiQDl4+5BE6+lRthw/o0M yjivzBjUcHbTqbDLvT7YtAhXsJy+NlSBA2TjY05nXrjwT6KQaQtabBKn8mW9xiZaGgv0 j0Fet2JT/dqyM0iBWKUe+JtBWTD0LO4zDKLKvyQZPdB1w5R6zkUtULkQIs+NewoTxrCP iI3g== ARC-Authentication-Results: i=1; gmr-mx.google.com; dkim=pass header.i=@berkeley-edu.20150623.gappssmtp.com header.s=20150623 header.b=m9TJxPqv; spf=pass (google.com: domain of jgm-TVLZxgkOlNX2fBVCVOL8/A@public.gmane.org designates 2607:f8b0:4864:20::635 as permitted sender) smtp.mailfrom=jgm-TVLZxgkOlNX2fBVCVOL8/A@public.gmane.org Original-Received: from mail-pl1-x635.google.com (mail-pl1-x635.google.com. [2607:f8b0:4864:20::635]) by gmr-mx.google.com with ESMTPS id u24si293716plq.4.2021.05.27.14.16.23 for (version=TLS1_3 cipher=TLS_AES_128_GCM_SHA256 bits=128/128); Thu, 27 May 2021 14:16:23 -0700 (PDT) Received-SPF: pass (google.com: domain of jgm-TVLZxgkOlNX2fBVCVOL8/A@public.gmane.org designates 2607:f8b0:4864:20::635 as permitted sender) client-ip=2607:f8b0:4864:20::635; Original-Received: by mail-pl1-x635.google.com with SMTP id s4so567945plg.12 for ; Thu, 27 May 2021 14:16:23 -0700 (PDT) X-Received: by 2002:a17:90a:ba07:: with SMTP id s7mr424456pjr.129.1622150182802; Thu, 27 May 2021 14:16:22 -0700 (PDT) Original-Received: from johnmacfarlane.net (li55-134.members.linode.com. [74.82.3.134]) by smtp.gmail.com with ESMTPSA id q9sm2648674pjm.23.2021.05.27.14.16.21 (version=TLS1_3 cipher=TLS_AES_256_GCM_SHA384 bits=256/256); Thu, 27 May 2021 14:16:22 -0700 (PDT) Original-Received: by johnmacfarlane.net (Postfix, from userid 1000) id 2E978A2A1; Thu, 27 May 2021 17:16:11 -0400 (EDT) In-Reply-To: X-Original-Sender: jgm-TVLZxgkOlNX2fBVCVOL8/A@public.gmane.org X-Original-Authentication-Results: gmr-mx.google.com; dkim=pass header.i=@berkeley-edu.20150623.gappssmtp.com header.s=20150623 header.b=m9TJxPqv; spf=pass (google.com: domain of jgm-TVLZxgkOlNX2fBVCVOL8/A@public.gmane.org designates 2607:f8b0:4864:20::635 as permitted sender) smtp.mailfrom=jgm-TVLZxgkOlNX2fBVCVOL8/A@public.gmane.org Precedence: list Mailing-list: list pandoc-discuss-/JYPxA39Uh5TLH3MbocFFw@public.gmane.org; contact pandoc-discuss+owners-/JYPxA39Uh5TLH3MbocFFw@public.gmane.org List-ID: X-Google-Group-Id: 1007024079513 List-Post: , List-Help: , List-Archive: , List-Unsubscribe: , Xref: news.gmane.io gmane.text.pandoc:28474 Archived-At: Do you have a folder ~/.pandoc or ~/.local/share/pandoc that contains reference.docx? Julio Vera writes: > Hi! I don't understand what about the "reference.docx", but in my folder= =20 > where I have the .md file I only have another .pdf file.=20 > > The command I use is: pandoc pxdxcomp.md -o pxdxcomp.docx > El jueves, 27 de mayo de 2021 a las 14:04:36 UTC-5, John MacFarlane=20 > escribi=C3=B3: > >> Also, please let us know the full command you are using to >> convert (including any options). >> >> John MacFarlane writes: >> >> > Make sure you don't have a reference.docx in your user data >> > directory. >> > >> > Julio Vera writes: >> > >> >> The latest one available in pandoc.org, I ran the script to uninstall= =20 >> it=20 >> >> and then downloaded it again for macOS.=20 >> >> >> >> I tested again with this file (prueba.md) that I created just to see = if=20 >> it=20 >> >> woks with new files but I got the same result. >> >> >> >> [image: Captura de Pantalla 2021-05-27 a la(s) 12.54.14.png] >> >> However, when I convert the dxprevcovid19.md to .docx the table there= =20 >> >> renders fine.=20 >> >> >> >> El jueves, 27 de mayo de 2021 a las 12:49:09 UTC-5, John MacFarlane= =20 >> >> escribi=C3=B3: >> >> >> >>> >> >>> That's very strange -- it looks like it is using extremely narrow >> >>> columns. But I can't reproduce this with latest pandoc. It >> >>> looks fine. What version are you using? >> >>> >> >>> Julio Vera writes: >> >>> >> >>> > [image: Captura de Pantalla 2021-05-27 a la(s) 12.27.20.png] >> >>> > >> >>> > Corrected it, but the tables are still not rendering. That's how I= =20 >> see=20 >> >>> the=20 >> >>> > tables inside the docx just for that file (pxdxcomp.md), when I=20 >> convert=20 >> >>> it=20 >> >>> > to pdf they render fine.=20 >> >>> > >> >>> > El jueves, 27 de mayo de 2021 a las 12:17:28 UTC-5, John MacFarlan= e=20 >> >>> > escribi=C3=B3: >> >>> > >> >>> >> >> >>> >> Looks like you've got four ---- instead of three --- under the >> >>> >> YAML metadata block. >> >>> >> >> >>> >> >> >>> >> Julio Vera writes: >> >>> >> >> >>> >> > Hi!=20 >> >>> >> > >> >>> >> > I attached 2 files. The one that I can't convert correctly is= =20 >> >>> >> pxdxcomp.md,=20 >> >>> >> > the other one (dxprevcovid) I tried to convert it and had no=20 >> issue.=20 >> >>> The=20 >> >>> >> > language of my work is in Spanish, I hope it isn't an issue her= e.=20 >> I=20 >> >>> >> tried=20 >> >>> >> > copying everything and pasting it inside a new file but still= =20 >> have=20 >> >>> the=20 >> >>> >> same=20 >> >>> >> > problem, also I uninstalled and installed pandoc. >> >>> >> > >> >>> >> > El jueves, 27 de mayo de 2021 a las 12:00:09 UTC-5, John=20 >> MacFarlane=20 >> >>> >> > escribi=C3=B3: >> >>> >> > >> >>> >> >> >> >>> >> >> Not much we can do to help without seeing the input markdown= =20 >> file... >> >>> >> >> >> >>> >> >> Julio Vera writes: >> >>> >> >> >> >>> >> >> > I usually just ran the following command: >> >>> >> >> > >> >>> >> >> > pandoc nameofile.md --citeproc -o nameofile.docx >> >>> >> >> > >> >>> >> >> > But today I was working with a particular .md file and after= I=20 >> >>> >> finished=20 >> >>> >> >> > with it I tried to convert it, but the title, date and autho= r=20 >> >>> >> parameters=20 >> >>> >> >> > that go inside the YAML block aren't converted, they display= =20 >> like=20 >> >>> >> this: >> >>> >> >> > >> >>> >> >> > title: title of the document >> >>> >> >> > author: myname >> >>> >> >> > date: today >> >>> >> >> > >> >>> >> >> > But just in that format, not like it used to do. And also th= e=20 >> >>> tables=20 >> >>> >> >> aren't=20 >> >>> >> >> > formatted, they and up in the docs like this: >> >>> >> >> > >> >>> >> >> > p t >> >>> >> >> > r 2 >> >>> >> >> > 1 2 >> >>> >> >> > 2 2 >> >>> >> >> > >> >>> >> >> > Just to say an example. I don't know hat happened. >> >>> >> >> > >> >>> >> >> > --=20 >> >>> >> >> > You received this message because you are subscribed to the= =20 >> Google=20 >> >>> >> >> Groups "pandoc-discuss" group. >> >>> >> >> > To unsubscribe from this group and stop receiving emails fro= m=20 >> it,=20 >> >>> >> send=20 >> >>> >> >> an email to pandoc-discus...-/JYPxA39Uh5TLH3MbocFF+G/Ez6ZCGd0@public.gmane.org >> >>> >> >> > To view this discussion on the web visit=20 >> >>> >> >>=20 >> >>> >>=20 >> >>>=20 >> https://groups.google.com/d/msgid/pandoc-discuss/1abeeca5-7362-441d-907a= -08df53958b28n%40googlegroups.com >> >>> >> >> . >> >>> >> >> >> >>> >> > >> >>> >> > --=20 >> >>> >> > You received this message because you are subscribed to the=20 >> Google=20 >> >>> >> Groups "pandoc-discuss" group. >> >>> >> > To unsubscribe from this group and stop receiving emails from i= t,=20 >> >>> send=20 >> >>> >> an email to pandoc-discus...-/JYPxA39Uh5TLH3MbocFF+G/Ez6ZCGd0@public.gmane.org >> >>> >> > To view this discussion on the web visit=20 >> >>> >>=20 >> >>>=20 >> https://groups.google.com/d/msgid/pandoc-discuss/eaeda4d3-c7f4-430f-b569= -e2fee781b831n%40googlegroups.com >> >>> >> . >> >>> >> > --- >> >>> >> > title: Diagn=C3=B3stico situacional sobre la prevalencia de SAR= S-COV-2=20 >> en=20 >> >>> >> perros, gatos y hurones de propietarios previamente diagn=C3=B3st= icados=20 >> con=20 >> >>> el=20 >> >>> >> virus. >> >>> >> > author: Julio Vera de Le=C3=B3n >> >>> >> > date: 25/Mayo/2021 >> >>> >> > bibliography: proyecto.bib >> >>> >> > csl: vca.csl >> >>> >> > --- >> >>> >> > >> >>> >> > # T=C3=ADtulo >> >>> >> > **H. CONSEJO T=C3=89CNICO DE LA FACULTAD** >> >>> >> > **DE MEDICINA VETERINARIA Y ZOOTECNIA** >> >>> >> > >> >>> >> > **Presente** >> >>> >> > >> >>> >> > =C3=89l que suscribe, **Julio Vera de Le=C3=B3n**, alumnos de l= a Maestr=C3=ADa=20 >> en=20 >> >>> >> Medicina Veterinaria y Zootecnia en el =C3=A1rea de Salud P=C3=BA= blica y=20 >> Medicina=20 >> >>> >> Preventiva, con n=C3=BAmero de cuenta 52101425-4. Pone a su=20 >> consideraci=C3=B3n el=20 >> >>> >> siguiente tema para diagn=C3=B3stico de situaci=C3=B3n: >> >>> >> > >> >>> >> > **Diagn=C3=B3stico situacional sobre la prevalencia de SARS-COV= -2 en=20 >> >>> perros,=20 >> >>> >> gatos y hurones de propietarios previamente diagn=C3=B3sticados c= on el=20 >> >>> virus.** >> >>> >> > >> >>> >> > Que ser=C3=A1 realizado en el **Departamento de Medicina Preven= tiva y=20 >> >>> Salud=20 >> >>> >> P=C3=BAblica de la Facultad de Medicina Veterinaria y Zootecnia d= e la=20 >> UNAM**=20 >> >>> y=20 >> >>> >> que pertenece al campo de profundizaci=C3=B3n profesional: **Medi= cina=20 >> >>> Preventiva=20 >> >>> >> y Salud P=C3=BAblica**. Bajo la asesor=C3=ADa del comit=C3=A9 tut= or conformado por=20 >> el=20 >> >>> >> **Dr. MSP Juan Ram=C3=B3n Ayala Torres**, la **MCV. Patricia Mora= =20 >> Medina** y=20 >> >>> el=20 >> >>> >> **MCV. Jorge Francisco Monroy L=C3=B3pez** >> >>> >> > >> >>> >> > # Introducci=C3=B3n >> >>> >> > >> >>> >> > El sustento de este diagn=C3=B3stico de situaci=C3=B3n viene de= que a la=20 >> fecha=20 >> >>> es=20 >> >>> >> desconocido por el autor alg=C3=BAn material bibliogr=C3=A1fico o= de consulta=20 >> en=20 >> >>> el=20 >> >>> >> que se tengan datos referentes al n=C3=BAmero de animales que han= sido=20 >> >>> >> infectados por el s=C3=ADndrome respiratorio agudo severo coronav= irus 2=20 >> >>> >> (SARS-COV-2). Esto a pesar de que la infecci=C3=B3n en los animal= es por=20 >> >>> >> SARS-COV-2 cumple los criterios de la OIE como enfermedad=20 >> emergente.[^1] >> >>> >> > >> >>> >> > Es relevante tener datos que nos permitan conocer la prevalenci= a=20 >> del=20 >> >>> >> agente en los animales de compa=C3=B1=C3=ADa con los que mantenem= os una=20 >> relaci=C3=B3n=20 >> >>> m=C3=A1s=20 >> >>> >> cercana. >> >>> >> > >> >>> >> > [^1]: Enfermedad emergente por la OIE: La aparici=C3=B3n de una= =20 >> >>> enfermedad,=20 >> >>> >> infecci=C3=B3n o infestaci=C3=B3n nueva y que impacta en la sanid= ad animal o=20 >> la=20 >> >>> salud=20 >> >>> >> humana. >> >>> >> > >> >>> >> > A la fecha existen al menos 4 distintas instituciones en Am=C3= =A9rica=20 >> que=20 >> >>> >> est=C3=A1n realizando estudios de muestreo para conocer la cantid= ad de=20 >> >>> animales=20 >> >>> >> de compa=C3=B1ia infectados por contacto con sus propietarios, la= s=20 >> cuales=20 >> >>> son: >> >>> >> > >> >>> >> > 1. [Ontario Veterinary College, University of Guelph]( >> >>> >> https://ovc.uoguelph.ca) >> >>> >> > 2. [Cummings School of Veterinary Medicine at Tufts University]= ( >> >>> >> https://sites.tufts.edu/covers/) >> >>> >> > 3. [Texas A&M University, College of Veterinary Medicine &=20 >> Biomedical=20 >> >>> >> Sciences](https://vetmed.tamu.edu/hamer-lab/covid-19-pets-researc= h/ >> ) >> >>> >> > 4. [University of Washington Center for One Health Research]( >> >>> >> https://deohs.washington.edu/cohr/covid-19-and-pets-study-caps) >> >>> >> > >> >>> >> > La evidencia apunta a que la epidemia provocada por SARS-COV-2 = se=20 >> >>> >> mantiene principalmente por la transmisi=C3=B3n de humanos hacia = otros=20 >> >>> humanos,=20 >> >>> >> por lo que en este estudio el enfoque ser=C3=A1 conocer la cantid= ad de=20 >> >>> animales=20 >> >>> >> que han sido infectados por sus propietarios, factores que=20 >> >>> contribuyeron a=20 >> >>> >> la infecci=C3=B3n, y conocer los tipos de casa en los que hubo m= =C3=A1s=20 >> riesgo de=20 >> >>> >> infecci=C3=B3n a las mascotas. Aunado a lo anterior, la OIE no de= scarta=20 >> a=20 >> >>> los=20 >> >>> >> animales salvajes y dom=C3=A9sticos como reservorios futuros de l= a=20 >> >>> enfermedad y=20 >> >>> >> que puedan representar un problema para la salud p=C3=BAblica, po= r lo=20 >> que=20 >> >>> >> sugiere el monitoreo cercano de las especies con las que m=C3=A1s= =20 >> >>> convivimos. De=20 >> >>> >> igual forma, la introducci=C3=B3n constante del virus a nuevas=20 >> poblaciones=20 >> >>> >> animales puede llevar a mutaciones que puedan afectar la sanidad= =20 >> animal=20 >> >>> o=20 >> >>> >> salud humana. >> >>> >> > >> >>> >> > A la fecha la OIE cuenta con informaci=C3=B3n referente a las e= species=20 >> de=20 >> >>> >> inter=C3=A9s en este diagn=C3=B3stico en cu=C3=A1nto a la suscept= ibilidad que=20 >> tienen=20 >> >>> al=20 >> >>> >> virus, se pone en la siguiente tabla:[@OIE2021] >> >>> >> > >> >>> >> > | Especie | Tipo de infecci=C3=B3n | Susceptibilidad a la infec= ci=C3=B3n |=20 >> >>> Signos=20 >> >>> >> cl=C3=ADnicos | Transmisi=C3=B3n | >> >>> >> > | ------------------ | ---------------------- |=20 >> >>> >> ------------------------------ | -------------------------- |=20 >> >>> >> ----------------- | >> >>> >> > | Hurones | Natural y experimental | Alta | S=C3=AD (s=C3=B3lo = en algunos=20 >> >>> casos) |=20 >> >>> >> S=C3=AD, entre hurones | >> >>> >> > | Gatos (dom=C3=A9sticos) | Natural y experimental | Alta | S= =C3=AD (s=C3=B3lo=20 >> en=20 >> >>> >> algunos casos) | S=C3=AD, entre gatos | >> >>> >> > | Perros | Natural y experimental | Baja | S=C3=AD (s=C3=B3lo e= n algunos=20 >> casos)=20 >> >>> |=20 >> >>> >> No | >> >>> >> > Table: SARS-COV-2 en Hurones, perros y gatos (adaptado de la OI= E) >> >>> >> > >> >>> >> > A pesar de que la informaci=C3=B3n actual ha mencionado que la= =20 >> epidemia se=20 >> >>> >> mantiene por medio de la transmisi=C3=B3n humano-humano, no se pu= ede=20 >> >>> descartar=20 >> >>> >> como un componente de esta cadena de transmisi=C3=B3n a los anima= les de=20 >> >>> >> compa=C3=B1ia, aunque su papel de momento sea mucho menos relevan= te. De=20 >> ah=C3=AD=20 >> >>> que=20 >> >>> >> una de las indicaciones que contempla la CDC sea la de mantener a= =20 >> los=20 >> >>> >> animales separados junto con su propietario y reconoce el riesgo = de=20 >> >>> >> transmisi=C3=B3n desde la mascota es bajo. [@CDC2021] >> >>> >> > >> >>> >> > # Justificaci=C3=B3n >> >>> >> > >> >>> >> > La detecci=C3=B3n del material gen=C3=A9tico del virus de SARS-= COV-2 en=20 >> perros=20 >> >>> y=20 >> >>> >> gatos se ha demostrado en animales con y sin signolog=C3=ADa, as= =C3=AD como=20 >> >>> tambi=C3=A9n=20 >> >>> >> en el suero de mascotas que se han muestreado en zonas afectadas,= =20 >> por=20 >> >>> lo=20 >> >>> >> que la infecci=C3=B3n en estas especies est=C3=A1 comprobada, y m= =C3=A1s=20 >> importante se=20 >> >>> ha=20 >> >>> >> comprobado que llegan a diseminar material viral con una cantidad= =20 >> >>> necesaria=20 >> >>> >> que ha demostrado ser capaz de infectar a otros animales con los= =20 >> que=20 >> >>> >> conviven. @Patterson2020 >> >>> >> > >> >>> >> > En contraste con lo mencionado anteriormente, las especies de= =20 >> >>> producci=C3=B3n=20 >> >>> >> como cerdos (*Sus scropha*) y aves (gallinas, patos y pavos) han= =20 >> >>> demostrado=20 >> >>> >> de nula a extremadamente baja susceptiblidad de infecci=C3=B3n de= manera=20 >> >>> >> experimental, adem=C3=A1s de que no se ha comprobado sean capaces= de=20 >> >>> transmitir=20 >> >>> >> la enfermedad. @Shi2020 De manera similar los bovinos (*Bos=20 >> taurus*)=20 >> >>> que se=20 >> >>> >> han inoculado experimentalmente con el agente viral han demostrad= o=20 >> una=20 >> >>> >> susceptibilidad baja al agente y nula capacidad de transmisi=C3= =B3n del=20 >> >>> mismo.=20 >> >>> >> @Ulrich2020=20 >> >>> >> > >> >>> >> > Debido a que las especies usadas com=C3=BAnmente en la ganader= =C3=ADa no=20 >> han=20 >> >>> >> demostrado ser suceptibles al virus, se decide enfocar el=20 >> diagn=C3=ADstico=20 >> >>> de=20 >> >>> >> situaci=C3=B3n en perros, gatos y hurones. De estos tres es de=20 >> particular=20 >> >>> >> relevancia mencionar a los hurones dom=C3=A9sticos (*Mustela outo= rius=20 >> >>> furo*), ya=20 >> >>> >> que pertenecen a la familia *Mustelidae* y guardan una relaci=C3= =B3n=20 >> >>> taxon=C3=B3mica=20 >> >>> >> con los must=C3=A9lidos usados en granjas como lo es el vis=C3=B3= n americano=20 >> >>> >> (*Neovison vison*) y vis=C3=B3n europeo (*Mustela lutreola*), est= os=20 >> =C3=BAltimos=20 >> >>> >> responsables del brote de SARS-COV-2 que llev=C3=B3 a la eutanasi= a de 17=20 >> >>> >> millones de visones.[^2]=20 >> >>> >> > >> >>> >> > Aunque los hurones dom=C3=A9sticos frecuentemente se encuentran= =20 >> separados=20 >> >>> de=20 >> >>> >> otros y no son capaces de mantener la propagaci=C3=B3n del virus = de=20 >> manera=20 >> >>> >> estable @Gortazar2021, el gobierno del Reino Unido ha emitido una= =20 >> gu=C3=ADa=20 >> >>> >> especial para los due=C3=B1os de estos animales debido al riesgo = que=20 >> pueden=20 >> >>> >> representar [^3].=20 >> >>> >> > >> >>> >> > [^2]: [=C2=BFPor qu=C3=A9 Dinamarca sacrific=C3=B3 17 millones = de visones?]( >> >>> >>=20 >> >>>=20 >> https://www.nbcnews.com/news/animal-news/here-s-why-denmark-culled-17-mi= llion-minks-now-plans-n1249610 >> >>> >> ) >> >>> >> > >> >>> >> > [^3]: [Medidas preventivas en lo que respecta al SARS-COV-2 y l= os=20 >> >>> >> hurones en el Reino Unido]( >> >>> >> http://apha.defra.gov.uk/documents/guidance-sars-cov-2-ferrets.pd= f) >> >>> >> > >> >>> >> > Es as=C3=AD que en consideraci=C3=B3n al C=C3=B3digo Sanitario = para los Animales=20 >> >>> >> Terrestres que contempla al SARS-COV-2 como una enfermedad=20 >> emergente y=20 >> >>> la=20 >> >>> >> falta de datos al respecto de la enfermedad en los animales=20 >> dom=C3=A9sticos,=20 >> >>> es=20 >> >>> >> necesario realizar un diagn=C3=B3stico de situaci=C3=B3n en nuest= ra=20 >> poblaci=C3=B3n.=20 >> >>> >> > >> >>> >> > # Referencias >> >>> >> > --- >> >>> >> > title: Ejercicio de pruebas diagn=C3=B3sticas complementarias >> >>> >> > author: Julio Vera de Le=C3=B3n >> >>> >> > date: 26/Mayo/2021 >> >>> >> > ---- >> >>> >> > >> >>> >> > # Primer prueba >> >>> >> > >> >>> >> > La primer prueba tamiz que se usa para brucelosis es la de anil= lo=20 >> en=20 >> >>> >> leche.=20 >> >>> >> > >> >>> >> > Se hizo un diagn=C3=B3stico con la prueba tamiz de anillo en le= che=20 >> para=20 >> >>> >> detectar a los hatos positivos a la enfermedad, estos hatos cuent= an=20 >> con=20 >> >>> >> 10.000 animales, los cuales fueron evaluados individualmente para= =20 >> >>> encontrar=20 >> >>> >> los positivos; a trav=C3=A9s de la prueba tamiz de rosa de bengal= a la=20 >> cual=20 >> >>> tiene=20 >> >>> >> una sensibilidad del 95.2% y una especificidad del 98.5%. >> >>> >> > >> >>> >> > | Prueba | Positivos | Negativos | Total | >> >>> >> > | --------- | --------- | --------- | ----- | >> >>> >> > | Positivos | 286 | 145 | 431 | >> >>> >> > | Negativos | 14 | 9555 | 9569 | >> >>> >> > | Total | 300 | 9700 | 10000 | >> >>> >> > >> >>> >> > 1. Sanos: 9555 >> >>> >> > 2. Enfermos postprueba: 286 >> >>> >> > 3. Falsos positivos: 145 >> >>> >> > 4. Falsos negativos: 14 >> >>> >> > 5. Valor predictivo positivo: 66% >> >>> >> > 6. Valor predictivo negativo: 99% >> >>> >> > 7. Positivos a la prueba: 431 animales positivos, incluyendo=20 >> falsos=20 >> >>> >> positivos.=20 >> >>> >> > >> >>> >> > Son muchos animales (431) que se van a eliminar incluyendo los= =20 >> 145=20 >> >>> >> falsos positivos, sacrificando 145 animales que no deber=C3=ADan= =20 >> >>> sacrificarse,=20 >> >>> >> por lo que es necesario despu=C3=A9s de la prueba tamiz realizar = una=20 >> prueba=20 >> >>> >> mucho m=C3=A1s especifica, por lo que se sugierte una prueba con = mas=20 >> >>> >> especificidad para bajar la cantidad de falsos positivos.=20 >> >>> >> > >> >>> >> > # Segunda prueba >> >>> >> > >> >>> >> > La siguiente prueba se hace en paralelo, la norma dice que la= =20 >> segunda=20 >> >>> >> prueba es la *prueba de ribanol*. Esta tiene una sensibilidad del= =20 >> 96.4%=20 >> >>> y=20 >> >>> >> especificidad de 98.7% >> >>> >> > >> >>> >> > Cuadro de 2x2:=20 >> >>> >> > >> >>> >> > | Prueba | Positivos | Negativos | Total | >> >>> >> > | --------- | --------- | --------- | ----- | >> >>> >> > | Positivos | 276 | 2 | 278 | >> >>> >> > | Negativos | 10 | 143 | 153 | >> >>> >> > | Total | 286 | 145 | 431 | >> >>> >> > >> >>> >> > 1. En que animales se aplicar=C3=ADa? Sobre el total de positiv= os, que=20 >> >>> ser=C3=ADa=20 >> >>> >> 431 >> >>> >> > 2. Verdaderos positivos: 276 >> >>> >> > 3. Verdaderamente sanos: 143 >> >>> >> > 4. Falsos positivos: 2 >> >>> >> > 5. Falsos negativos: 10 >> >>> >> > 6. Valor predicitvo positivo: 99%=20 >> >>> >> > 7. Valor predictivo negativo: 93% >> >>> >> > >> >>> >> > # Tercer prueba >> >>> >> > >> >>> >> > Al realizar un tercer diagn=C3=B3stico con la prueba de fijaci= =C3=B3n del=20 >> >>> >> complemento (confirmatoria) con una sensibilidad del 97.5% y=20 >> >>> especificidad=20 >> >>> >> del 99% >> >>> >> > >> >>> >> > Cuadro 2 x2: >> >>> >> > >> >>> >> > | Prueba | Positivos | Negativos | Total | >> >>> >> > | --------- | --------- | --------- | ----- | >> >>> >> > | Positivos | 269 | 0 | 269 | >> >>> >> > | Negativos | 7 | 2 | 9 | >> >>> >> > | Total | 276 | 2 | 278 | >> >>> >> > >> >>> >> > 1. Animales falsos positivos que seran eliminados: 0 >> >>> >> > 2. Animales falsos negativos que quedar=C3=A1n en el hato: 7 >> >>> >> > 3. Valor predictivo positivo: 100%. Quiere decir que de los=20 >> animales=20 >> >>> a=20 >> >>> >> los que se les hace la prueba y est=C3=A1n enfermos, el 100% sald= r=C3=A1n con=20 >> un=20 >> >>> >> respultado positivo. >> >>> >> > 4. Valor predictivo negativo: 22%. Quiere decir de los animales= a=20 >> los=20 >> >>> >> que se les hace la prueba y est=C3=A1n sanos, solamente el 22% ti= ene=20 >> >>> >> probabilidad de estar realmente sano si sali=C3=B3 negativo.=20 >> >>> >> >=20 >> >>> >> > # Despu=C3=A9s de las pruebas >> >>> >> > >> >>> >> > Al realizar un diagn=C3=B3stico a los 6 meses de iniciado el pr= ograma: >> >>> >> > >> >>> >> > 1. =C2=BFCu=C3=A1l es la prevalencia real final de la enfermeda= d en la=20 >> cuenca=20 >> >>> >> lechera? 2.8% (278/10000) >> >>> >> > 2. La prevalencia real en el 3er cuadro: 99.3%=20 >> >>> >> > 3. =C2=BFCu=C3=A1l es la prevalencia aparente en el 3er cuadro?= 2.7% () >> >>> >> > 4. Repercusiones de dejar a los animales falsos negativos en el= =20 >> hato=20 >> >>> es=20 >> >>> >> que se quedan 7 animales con brucella, que pueden seguir=20 >> contagiando y=20 >> >>> >> prevalece la enfermedad.=20 >> >>> >> > >> >>> >> > El costo de la prueba da anillo en leche es absorbido por el=20 >> gobierno=20 >> >>> >> como una ayuda a los productoras y un incentivo para erradicar es= ta=20 >> >>> >> zoonosis de tos animales. Sin embargo, el costo de las dem=C3=A1s= =20 >> pruebas es=20 >> >>> >> erogado por los productores: >> >>> >> > >> >>> >> > 1. Costo de diagnosticar a los 10,000 animales con rosa de=20 >> bengala=20 >> >>> >> (anillo en leche), si esta prueba cuesta $0.15 por 100 animales: = 15=20 >> >>> pesos >> >>> >> > 2. Costo de diagnosticar $1 por 100: ser=C3=ADan $4.3 >> >>> >> > 3. Costo de diagnosticar fijaci=C3=B3n por complemento $500 por= 100=20 >> >>> animales:=20 >> >>> >> $1390 >> >>> >> > 4. Costo de eliminar a los animales positivos y falsos positivo= s=20 >> >>> >> (separadamente), si una vaquilla de reemplazo cuesta $1,000=20 >> dolares.=20 >> >>> Costo=20 >> >>> >> de positivos: $278,000 dolares.=20 >> >>> >> > 5. Costo total de las 3 pruebas y de los animales a sacrificar:= =20 >> De=20 >> >>> las 3=20 >> >>> >> pruebas son $1409.3 pesos.=20 >> >>> >> >> >>> > >> >>> > --=20 >> >>> > You received this message because you are subscribed to the Google= =20 >> >>> Groups "pandoc-discuss" group. >> >>> > To unsubscribe from this group and stop receiving emails from it,= =20 >> send=20 >> >>> an email to pandoc-discus...-/JYPxA39Uh5TLH3MbocFF+G/Ez6ZCGd0@public.gmane.org >> >>> > To view this discussion on the web visit=20 >> >>>=20 >> https://groups.google.com/d/msgid/pandoc-discuss/edd6a94c-a735-494d-88c5= -bacabb6842b0n%40googlegroups.com >> >>> . >> >>> >> >> >> >> --=20 >> >> You received this message because you are subscribed to the Google=20 >> Groups "pandoc-discuss" group. >> >> To unsubscribe from this group and stop receiving emails from it, sen= d=20 >> an email to pandoc-discus...-/JYPxA39Uh5TLH3MbocFF+G/Ez6ZCGd0@public.gmane.org >> >> To view this discussion on the web visit=20 >> https://groups.google.com/d/msgid/pandoc-discuss/932560f4-7866-4fd4-90e7= -4797e23fab20n%40googlegroups.com >> . >> >> >> >> Table tests to see if it works >> >> >> >> | Perros | Talla | Peso | Nombre | >> >> | ------ | ----- | ---- | ------ | >> >> | 23 | 5 | 6 | Chicu | >> >> | 24 | 2 | 4 | Fala | >> >> | 45 | 8 | 10 | Frty | >> >> Table: Perros 1 >> >> >> >> Another table >> >> >> >> | Perros | Talla | Peso | Nombre | >> >> | ------ | ----- | ---- | ------ | >> >> | 23 | 5 | 6 | Chicu | >> >> | 24 | 2 | 4 | Fala | >> >> | 45 | 8 | 10 | Frty | >> >> Table: Perros 2 >> >> >> >> And another table >> >> >> >> | Perros | Talla | Peso | Nombre | >> >> | ------ | ----- | ---- | ------ | >> >> | 23 | 5 | 6 | Chicu | >> >> | 24 | 2 | 4 | Fala | >> >> | 45 | 8 | 10 | Frty | >> >> Table: Perros 3 >> > > --=20 > You received this message because you are subscribed to the Google Groups= "pandoc-discuss" group. > To unsubscribe from this group and stop receiving emails from it, send an= email to pandoc-discuss+unsubscribe-/JYPxA39Uh5TLH3MbocFF+G/Ez6ZCGd0@public.gmane.org > To view this discussion on the web visit https://groups.google.com/d/msgi= d/pandoc-discuss/ba007430-af22-455f-a4a8-96011afe5dc3n%40googlegroups.com. --=20 You received this message because you are subscribed to the Google Groups "= pandoc-discuss" group. To unsubscribe from this group and stop receiving emails from it, send an e= mail to pandoc-discuss+unsubscribe-/JYPxA39Uh5TLH3MbocFF+G/Ez6ZCGd0@public.gmane.org To view this discussion on the web visit https://groups.google.com/d/msgid/= pandoc-discuss/m2im33ri78.fsf%40MacBook-Pro.hsd1.ca.comcast.net.